NGS analysis of this fragmented biopsy specimen containing approximately 41%‐60% estimated tumor cellularity revealed a KRAS mutation (VAF: 53%) and two IDH2 mutations (VAFs: 13% for p.R140Q and 17% for p.R172M) within different alleles (Table 1). This evidence concerns the gene IDH2 and neoplasm.